Company / Total Assets
Avidity Biosciences, Inc. Total Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$2.0B
FY2025
5-year range
$427.6M / $2.0B
FY2021-FY2025
Trend
+25.2%
vs FY2024
Sector context
#43 of 214
Health Care
What the data says
Avidity Biosciences, Inc.'s total assets of $2.0B is higher than 80% of companies in the Health Care sector (FY2025). Improved from $629M to $2.0B over the past 2 years.
Based on SEC 10-K filings.
$2.0B in FY2025 with a 5-year CAGR of +42.4%. Top quartile in the Health Care sector.
Improved from $629M to $2.0B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +45.3%
- 5-Year CAGR
- +42.4%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 214This company $2.0B Sector average $7.5B
▼
-73.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +42.4%, indicating consistent growth.
- In FY2025, total assets increased 25.2% year-over-year.
- Ranks #43 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.0B | +25.2% |
| FY2024 | $1.6B | +148.8% |
| FY2023 | $628.6M | -1.6% |
| FY2022 | $638.8M | +49.4% |
| FY2021 | $427.6M | +28.1% |
| FY2020 | $333.9M | +244.6% |
| FY2019 | $96.9M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026